EN
HI
Ipca Laboratories Share Price
IPCALAB
1854.119.70 (1.07%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 19 Nov, 2026, Ipca Laboratories stock price is ₹1854.1. During the trading session, the stock has moved between an intraday low of ₹1834.00 and an intraday high of ₹1882.80. Over the last 52 weeks, Ipca Laboratories has traded between ₹1361.70 and ₹2038.00.
The stock has recorded a trading volume of 2,43,198 shares,. Its Average Traded Price (ATP) is ₹1863.55, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 19 @ ₹1854.10.
Ipca Laboratories has an upper circuit limit of ₹2201.20 and a lower circuit limit of ₹1467.60. The total value traded stands at ₹45.32 CR, and the delivery percentage for the day is 60.66%.
The stock is currently traded with a market lot size of 1. Ipca Laboratories also offers a dividend yield of 0.33%.
Ipca Laboratories Share Price Chart
Ipca Laboratories Share Key Metrics
Volume
2.43 L
Market Cap
47039.30 CR
LTQ@LTP
19@1854.10
ATP
1863.55
Var Margin
15.18 %
Circuit Range
1467.6-2201.2
Delivery %
60.66 %
Value
45.32 CR
ASM/GSM
No
Market Lot
1
Ipca Laboratories Resistance and Support
Pivot 1845.63
Resistance
First Resistance
1869.26
Second Resistance
1904.13
Third Resistance
1927.76
Support
First Support
1810.76
Second Support
1787.13
Third Support
1752.26
Ipca Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2025-26
- 2024-25
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
44.72%
Mutual Fund
29.63%
Insurance
5.19%
Foreign Institutional Investors
11.06%
Domestic Institutional Investors
0.86%
Retail
8.53%
Others
0.01%
Total Promoters
MAR '24
46.3%
JUN '24
46.3%
SEP '24
46.3%
DEC '24
44.72%
Ipca Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-13 | Quarterly Results |
| 2026-05-29 | Audited Results & Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Interim Dividend |
| 2024-09-30 | Others |
| 2024-08-13 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-07 | 2026-08-07 | View More |
Ipca Laboratories News
Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Management maintained FY27 revenue growth guidance of 14-16% and consolidated EBITDA margin at 22-23%. Q2 consolidated revenue grew 14% YoY to Rs.2,910 crore, with consolidated EBITDA margin improving to 22.97% driven by strong export and domestic formulation growth.
Nov 06 2026 17:31:33
Ipca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The Second Quarter And Half Year Ended 30.09.2026
IPCA Laboratories board of directors will meet on 5 November 2026 for financial results.
Oct 22 2026 11:40:23
Ipca Laboratories Management
| Name | Position |
|---|---|
| Harish P Kamath | Corporate Counsel & Company Secretary, Compliance Officer |
| Premchand Godha | Chairman |
Ipca Laboratories Similar Stocks
Fortis Healthcare Ltd.
793.55
-13.25 (1.64%)
Biocon Ltd.
361.95
2.55 (0.71%)
Gland Pharma Ltd.
3230.50
-17.90 (0.55%)
Abbott India Ltd.
25470.00
-345.00 (1.34%)
Anthem Biosciences Ltd.
914.35
-9.90 (1.07%)
Glaxosmithkline Pharmaceuticals Ltd.
2638.20
-49.40 (1.84%)
Emcure Pharmaceuticals Ltd.
2334.80
-4.60 (0.20%)
Ajanta Pharma Ltd.
3273.80
-38.70 (1.17%)
Narayana Hrudayalaya Ltd.
1891.30
-16.30 (0.85%)
Ipca Laboratories FAQs
The Buying Price of Ipca Laboratories share is 1854.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ipca Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ipca Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ipca Laboratories shares is 33.17. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ipca Laboratories shares is 5.36. Useful to assess the stock's value relative to its book value.
To assess Ipca Laboratories’s valuation compare Sector P/E, P/B which are 40.39 & 2.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ipca Laboratories is 47039.30 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ipca Laboratories share price is 2038.00 & 1361.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ipca Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in IPCALAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC